Portage Biotech (PRTG) Competitors $8.16 +0.07 (+0.87%) Closing price 03:58 PM EasternExtended Trading$8.22 +0.06 (+0.74%) As of 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRTG vs. KZR, FGEN, MRNS, INKT, ALLK, SCLX, CALC, GRCE, SRZN, and OKURShould you be buying Portage Biotech stock or one of its competitors? The main competitors of Portage Biotech include Kezar Life Sciences (KZR), FibroGen (FGEN), Marinus Pharmaceuticals (MRNS), MiNK Therapeutics (INKT), Allakos (ALLK), Scilex (SCLX), CalciMedica (CALC), Grace Therapeutics (GRCE), Surrozen (SRZN), and OnKure Therapeutics (OKUR). These companies are all part of the "pharmaceutical products" industry. Portage Biotech vs. Kezar Life Sciences FibroGen Marinus Pharmaceuticals MiNK Therapeutics Allakos Scilex CalciMedica Grace Therapeutics Surrozen OnKure Therapeutics Portage Biotech (NASDAQ:PRTG) and Kezar Life Sciences (NASDAQ:KZR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, community ranking, dividends and earnings. Do insiders & institutionals believe in PRTG or KZR? 13.4% of Portage Biotech shares are owned by institutional investors. Comparatively, 67.9% of Kezar Life Sciences shares are owned by institutional investors. 42.1% of Portage Biotech shares are owned by insiders. Comparatively, 10.4% of Kezar Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts prefer PRTG or KZR? Kezar Life Sciences has a consensus target price of $39.50, indicating a potential upside of 874.11%. Given Kezar Life Sciences' stronger consensus rating and higher probable upside, analysts clearly believe Kezar Life Sciences is more favorable than Portage Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Kezar Life Sciences 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has stronger valuation & earnings, PRTG or KZR? Portage Biotech has higher earnings, but lower revenue than Kezar Life Sciences. Kezar Life Sciences is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPortage BiotechN/AN/A-$75.34M-$41.65-0.19Kezar Life Sciences$7M4.23-$101.87M-$10.82-0.37 Does the MarketBeat Community prefer PRTG or KZR? Kezar Life Sciences received 124 more outperform votes than Portage Biotech when rated by MarketBeat users. However, 59.09% of users gave Portage Biotech an outperform vote while only 57.08% of users gave Kezar Life Sciences an outperform vote. CompanyUnderperformOutperformPortage BiotechOutperform Votes1359.09% Underperform Votes940.91% Kezar Life SciencesOutperform Votes13757.08% Underperform Votes10342.92% Which has more risk & volatility, PRTG or KZR? Portage Biotech has a beta of 0.48, meaning that its stock price is 52% less volatile than the S&P 500. Comparatively, Kezar Life Sciences has a beta of 0.61, meaning that its stock price is 39% less volatile than the S&P 500. Does the media refer more to PRTG or KZR? In the previous week, Kezar Life Sciences had 4 more articles in the media than Portage Biotech. MarketBeat recorded 4 mentions for Kezar Life Sciences and 0 mentions for Portage Biotech. Kezar Life Sciences' average media sentiment score of 0.91 beat Portage Biotech's score of 0.00 indicating that Kezar Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Portage Biotech Neutral Kezar Life Sciences Positive Is PRTG or KZR more profitable? Kezar Life Sciences' return on equity of -54.95% beat Portage Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Portage BiotechN/A -342.34% -196.47% Kezar Life Sciences N/A -54.95%-46.11% SummaryKezar Life Sciences beats Portage Biotech on 12 of the 16 factors compared between the two stocks. Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTG vs. The Competition Export to ExcelMetricPortage BiotechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.26M$6.45B$5.31B$8.42BDividend YieldN/A2.64%5.21%4.10%P/E Ratio-0.199.0426.7819.69Price / SalesN/A253.23386.97118.34Price / Cash0.5865.8538.2534.62Price / Book2.156.406.744.50Net Income-$75.34M$143.98M$3.23B$248.32M7 Day Performance6.29%1.90%1.49%-0.03%1 Month Performance-18.61%4.01%11.47%12.72%1 Year Performance58.28%-3.00%16.57%7.38% Portage Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTGPortage Biotech0.2966 of 5 stars$8.16+0.9%N/A+61.1%$8.56MN/A-0.206Upcoming EarningsGap UpKZRKezar Life Sciences4.1523 of 5 stars$4.23+0.2%$39.50+833.8%-48.3%$30.90M$7M-0.3260Gap UpFGENFibroGen4.3711 of 5 stars$0.31-0.8%$10.00+3,174.4%-72.1%$30.86M$29.62M-0.25570MRNSMarinus Pharmaceuticals1.8858 of 5 stars$0.55-0.2%$4.79+771.6%-58.7%$30.32M$30.99M-0.22110News CoverageAnalyst ForecastINKTMiNK Therapeutics2.6036 of 5 stars$7.60+8.1%$37.50+393.4%-22.2%$30.14MN/A-1.9530Earnings ReportAnalyst RevisionALLKAllakos4.2132 of 5 stars$0.33+0.3%$2.00+506.8%N/A$29.79MN/A-0.16190SCLXScilex1.5589 of 5 stars$4.10+2.2%$455.00+10,997.6%-87.8%$28.50M$56.59M-4.9480High Trading VolumeCALCCalciMedica2.4232 of 5 stars$2.01+0.5%$18.00+795.5%-67.6%$28.08MN/A-1.8630GRCEGrace Therapeutics1.8472 of 5 stars$2.72flat$12.00+341.2%N/A$27.58MN/A-2.34N/AGap UpSRZNSurrozen2.9899 of 5 stars$8.00-4.2%$38.50+381.3%-24.7%$26.25M$10.66M-0.3280OKUROnKure Therapeutics2.9273 of 5 stars$1.95+1.6%$32.33+1,558.1%N/A$26.20MN/A-0.16N/AInsider TradeGap Up Related Companies and Tools Related Companies Kezar Life Sciences Alternatives FibroGen Alternatives Marinus Pharmaceuticals Alternatives MiNK Therapeutics Alternatives Allakos Alternatives Scilex Alternatives CalciMedica Alternatives Grace Therapeutics Alternatives Surrozen Alternatives OnKure Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRTG) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRTG Stock Free PRTG Stock Alerts